Actuate Therapeutics Inc
ACTU | NASDAQ
$0.89
-$0.02 (-1.91%)
Sep 22, 2026, 11:27 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -4.91M | -5.71M | -4.69M | -5.47M | -5.97M | -6.37M | -6.56M | -5.39M | -5.44M | -7.77M | -7.62M | -6.48M | -5.58M | -5.3M |
Interest Income | 45.02K | 85.27K | 139.58K | 69.97K | 24.53K | 53.62K | 118.12K | 80.75K | 8.65K | 14.79K | 59.69K | 125.94K | 115.39K | 51.65K |
Pretax Income | -4.87M | -5.63M | -4.55M | -5.41M | -5.95M | -6.32M | -6.45M | -5.97M | -6.57M | -8.3M | -7.61M | -6.34M | -5.52M | -5.27M |
Net Income | -4.87M | -5.63M | -4.55M | -5.41M | -5.95M | -6.32M | -6.45M | -5.97M | -6.57M | -8.3M | -7.61M | -6.34M | -5.52M | -5.27M |
Selling & General & Admin | 2.84M | 3.14M | 2.56M | 3.29M | 3.2M | 3.15M | 2.87M | 1.64M | 1.06M | 912.82K | 969.35K | 714.17K | 807.18K | 774.8K |
Research & Development | 2.07M | 2.57M | 2.13M | 2.18M | 2.76M | 3.22M | 3.69M | 3.76M | 4.37M | 6.86M | 6.65M | 5.76M | 4.78M | 4.52M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | n/a |
Operating Expenses | 4.91M | 5.71M | 4.69M | 5.47M | 5.97M | 6.37M | 6.56M | 5.39M | 5.44M | 7.77M | 7.62M | 6.48M | 5.58M | 5.3M |
Interest Expense | 5.06K | 5.06K | 5.06K | 5.06K | 5.06K | 5.06K | 5.08K | 3.49K | 5.08K | 5.08K | 5.06K | 5.06K | 5.06K | 28.45K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.91M | 5.71M | 4.69M | 5.47M | 5.97M | 6.37M | 6.56M | 5.39M | 5.44M | 7.77M | 7.62M | 6.48M | 5.58M | 5.3M |
Income Tax Expense | n/a | n/a | 800 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 23.87M | 23.54M | 23.25M | 21.39M | 19.65M | 19.5M | 19.51M | 19.51M | 19.53M | 15.49M | 15.26M | 15.49M | 14.22M | 13.39M |
Shares Outstanding (Diluted) | 23.87M | 23.54M | 23.25M | 21.39M | 19.65M | 19.5M | 19.51M | 19.51M | 19.53M | 15.49M | 15.26M | 15.49M | 14.22M | 13.4M |
EPS (Basic) | -0.20 | -0.24 | -0.20 | -0.25 | -0.30 | -0.32 | -0.60 | -0.55 | -0.34 | -0.54 | -0.50 | -0.41 | -0.39 | -0.39 |
EPS (Diluted) | -0.20 | -0.24 | -0.20 | -0.25 | -0.30 | -0.32 | -0.60 | -0.55 | -0.34 | -0.54 | -0.50 | -0.41 | -0.39 | -0.39 |
EBITDA | -4.91M | -5.62M | -4.55M | -5.4M | -5.94M | -6.31M | -6.32M | -5.97M | -6.57M | -8.29M | -7.6M | -6.19M | 65.2K | 28.3K |
EBIT | -4.91M | -5.62M | -4.55M | -5.4M | -5.94M | -6.31M | -6.44M | -5.97M | -6.57M | -8.29M | -7.61M | -6.33M | -5.52M | -5.27M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | 118.12K | n/a | n/a | n/a | 8.09K | 142.81K | 5.58M | 5.3M |
Add to Watchlist
Select watchlists to add or remove ACTU